Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection.

Chen, Catherine; Amelia, Aisah; Ashdown, George W; Mueller, Ivo; Coussens, Anna K; Eriksson, Emily M

Chen, Catherine; Amelia, Aisah; Ashdown, George W; Mueller, Ivo; Coussens, Anna K; Eriksson, Emily M.

Afiliación

Chen C; The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.
Amelia A; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3052, Australia.
Ashdown GW; The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.
Mueller I; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3052, Australia.
Coussens AK; The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.
Eriksson EM; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3052, Australia.

Mol Med ; 27(1): 160, 2021 12 20.

Article en En | MEDLINE | ID: mdl-34930107

Asunto(s)

Autoanticuerpos/inmunología; Autoanticuerpos/metabolismo; COVID-19/complicaciones; COVID-19/inmunología; SARS-CoV-2/inmunología; Animales; Autoinmunidad/fisiología; COVID-19/metabolismo; Humanos; SARS-CoV-2/metabolismo; Síndrome Post Agudo de COVID-19

Palabras clave

Autoantibodies; Autoimmunity; COVID-19; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Autoanticuerpos / SARS-CoV-2 / COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Animals / Humans Idioma: En Revista: Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google